JOHN B HENNEMAN III Insider Trading $ANIK Anika Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN B HENNEMAN III.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN B HENNEMAN III. JOHN B HENNEMAN III is Director in Anika Therapeutics, Inc. ($ANIK) and Chief Administrative Officer in NEWLINK GENETICS CORP ($NLNK) and EVP, Chief Financial Officer in NEWLINK GENETICS CORP ($NLNK) and Director in Accretive Health, Inc. ($AH) and Director in SeaSpine Holdings Corp ($SPNE) and in Aprea Therapeutics, Inc. ($APRE).

JOHN B HENNEMAN III in Anika Therapeutics, Inc.

Trading Symbol: ANIK
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN B HENNEMAN III: Director
Holdings: 9,310 shares
Current Value: $468,293
Latest Transaction: Sep 08 2020
$ANIK Market Capitalization: $733.34M
$ANIK Previous Close: $50.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN B HENNEMAN III in Anika Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ANIK, APRE, NLNK, AH, SPNE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 08 2020ANIKAnika Therapeutics ...HENNEMAN JOHN B IIIDirectorGrantA0.009,31009,3100 to 9.3 K

Page:   1